StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS - Free Report) in a research note released on Sunday. The firm issued a hold rating on the stock.
Separately, Benchmark began coverage on shares of Milestone Scientific in a research report on Thursday, October 10th. They set a "speculative buy" rating and a $1.25 price target for the company.
Check Out Our Latest Research Report on Milestone Scientific
Milestone Scientific Trading Up 5.2 %
Milestone Scientific stock traded up $0.04 during midday trading on Friday, hitting $0.76. 131,535 shares of the company's stock were exchanged, compared to its average volume of 110,828. Milestone Scientific has a 12-month low of $0.52 and a 12-month high of $1.10. The firm's 50 day simple moving average is $0.89 and its 200 day simple moving average is $0.83.
Milestone Scientific (NYSE:MLSS - Get Free Report) last released its quarterly earnings results on Thursday, August 15th. The company reported ($0.02) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The company had revenue of $1.85 million for the quarter. Milestone Scientific had a negative return on equity of 60.78% and a negative net margin of 54.87%.
Insider Activity
In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of the company's stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the transaction, the director now directly owns 4,606,882 shares in the company, valued at approximately $4,284,400.26. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders have sold 251,106 shares of company stock worth $236,451 over the last ninety days. 24.75% of the stock is currently owned by insiders.
About Milestone Scientific
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Articles
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
